BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 7543136)

  • 21. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking of V beta 8.2-positive encephalitogenic T cells by complementarity-determining region 3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization.
    Sakuma H; Kohyama K; Jee Y; Matsumoto Y
    J Immunol; 2004 Oct; 173(7):4516-22. PubMed ID: 15383583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties.
    Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A
    J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
    Tabi Z; McCombe PA; Pender MP
    Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
    Matsumoto Y; Fujiwara M
    Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes.
    Offner H; Vainiene M; Gold DP; Celnik B; Wang R; Hashim GA; Vandenbark AA
    J Immunol; 1992 Mar; 148(6):1706-11. PubMed ID: 1371785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal injection of Lewis rats with recombinant V beta 8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis.
    Vainiene M; Burrows GG; Ariail K; Robey I; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Aug; 45(4):475-86. PubMed ID: 8872909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis.
    Offner H; Vainiene M; Celnik B; Weinberg AD; Buenafe A; Vandenbark AA
    J Immunol; 1994 Dec; 153(11):4988-96. PubMed ID: 7525721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice.
    Biasi G; Facchinetti A; Monastra G; Mezzalira S; Sivieri S; Tavolato B; Gallo P
    J Neuroimmunol; 1997 Mar; 73(1-2):117-23. PubMed ID: 9058767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.
    Duplan V; Beriou G; Heslan JM; Bruand C; Dutartre P; Mars LT; Liblau RS; Cuturi MC; Saoudi A
    J Immunol; 2006 Jan; 176(2):839-47. PubMed ID: 16393967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of TCR V beta 8 peptide protection and therapy on T cell populations isolated from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis.
    Weinberg AD; Celnik B; Vainiene M; Buenafe AC; Vandenbark AA; Offner H
    J Neuroimmunol; 1994 Jan; 49(1-2):161-70. PubMed ID: 8294553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
    Tan LJ; Vanderlugt CL; McRae BL; Miller SD
    Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of EAE by vaccination with T cell receptor peptides: V beta 8 T cell receptor peptide-specific CD4+ lymphocytes lack direct immunoregulatory activity.
    Jung S; Schluesener HJ; Toyka KV; Hartung HP
    J Neuroimmunol; 1993 Jun; 45(1-2):15-22. PubMed ID: 8101189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Huang YM; Yang JS; Xu LY; Link H; Xiao BG
    Clin Exp Immunol; 2000 Dec; 122(3):437-44. PubMed ID: 11122252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
    J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis.
    Yang JS; Xu LY; Huang YM; Van Der Meide PH; Link H; Xiao BG
    Immunology; 2000 Nov; 101(3):397-403. PubMed ID: 11106944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.